Showing results (61-70 of 101) with videos related to
Sort By:
Pageof 11
Cancer Discovery|August 29, 2019
Targeting Glioblastoma Stem Cells through Disruption of the Circadian ClockZhen Dong, Guoxin Zhang, Meng Qu, et al.Nature Genetics|November 26, 2013
Large conserved domains of low DNA methylation maintained by Dnmt3aMira Jeong, Deqiang Sun, Min Luo, et al.Biorxiv : the Preprint Server for Biology|August 8, 2025
Ras-Responsive Element Binding Protein 1 regulates survival of Group 3 medulloblastomaMeher Beigi Masihi, Kendall R Chambers, Richard A Friedman, et al.Proceedings of the National Academy of Sciences of the United States of America|November 23, 2019
Inhibition of dual-specificity tyrosine phosphorylation-regulated kinase 2 perturbs 26S proteasome-addicted neoplastic progressionSourav Banerjee, Tiantian Wei, Jue Wang, et al.Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
Extrachromosomal DNA associates with poor survival across a broad spectrum of childhood solid tumorsOwen S Chapman, Sunita Sridhar, Eugene Yui-Ching Chow, et al.Acta Neuropathologica|May 12, 2019
Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypesTanvi Sharma, Edward C Schwalbe, Daniel Williamson, et al.Neuro-Oncology|April 4, 2017
Telomerase activation in posterior fossa group A ependymomas is associated with dismal prognosis and chromosome 1q gainJohannes Gojo, Daniela Lötsch, Sabine Spiegl-Kreinecker, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2018
Extensive Molecular and Clinical Heterogeneity in Patients With Histologically Diagnosed CNS-PNET Treated as a Single Entity: A Report From the Children's Oncology Group Randomized ACNS0332 TrialEugene I Hwang, Marcel Kool, Peter C Burger, et al.Neuro-Oncology|August 22, 2020
Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastomaJonas Ecker, Venu Thatikonda, Gianluca Sigismondo, et al.Nature Medicine|September 12, 2017
A mouse model for embryonal tumors with multilayered rosettes uncovers the therapeutic potential of Sonic-hedgehog inhibitorsJulia E Neumann, Annika K Wefers, Sander Lambo, et al.Pageof 11